Semaglutide's heart benefits: new clues from completed trial
NCT ID NCT07190144
First seen Nov 01, 2025 · Last updated May 14, 2026 · Updated 27 times
Summary
This study examined whether semaglutide, a drug used for diabetes and weight loss, improves blood flow in the heart's arteries. Researchers measured coronary flow reserve in 122 diabetic and non-diabetic patients before and after 3 months of treatment. The goal was to understand the drug's vascular effects, not to test a new treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY & OVERWEIGHT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Medicana International Istanbul Hospital
Istanbul, 34520, Turkey (Türkiye)
Conditions
Explore the condition pages connected to this study.